[1] Danan G, Teschke R. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch? Drug Saf, 2018 Mar 3. doi: 10.1007/s40264-018-0654-2. Epub ahead of print.
[2] Danan G, Bénichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol, 1993, 46: 1323-1330.
[3] Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci, 2016, 17. https://doi.org/10.3390/ijms17010014. (Article 14).
[4] 于乐成, 陈成伟. 新版RUCAM:药物和草药诱导性肝损伤的重要评估工具. 肝脏, 2016, 21: 493-500,501.
[5] Rockey DC, Seeff LB, Rochon J, et al. US Drug-Induced Liver Injury Network. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology, 2010, 51:2117-2126. |
